Abstract: This application provides an uplink transmit power determining method, a related network device and storage medium. In the method, a terminal determines an uplink transmit power based on the repetition count of the UCI. (uplink control information) it receives from a network device. The repetition count of the UCI on a user side is adaptively configured based on a PL(path loss), an interference the and the low coverage level for a user currently accessing at a high coverage level so that a transmit power of the UCI is controlled and an avalanche effect caused by always selecting full-power uplink transmission is avoided.

Abstract: The disclosure is directed towards automatically tuning quantization-based approximate nearest neighbors (ANN) search methods and systems (e.g., search engines) to perform at the speed-recall pareto frontier. With a desired search cost or recall as input, the embodiments employ Lagrangian-based methods to perform constrained optimization on theoretically-grounded search cost and recall models. The resulting tunings, when paired with the efficient quantization-based ANN implementation of the embodiments, exhibit excellent performance on standard benchmarks while requiring minimal tuning or configuration complexity.

Abstract: Disclosed are a point cloud encoding and decoding method and device based on a two-dimensional regularization plane projection. The encoding method includes: acquiring original point cloud data; performing two-dimensional regularization plane projection on the original point cloud data to obtain a two-dimensional projection plane structure; obtaining a plurality of pieces of two-dimensional image information according to the two-dimensional projection plane structure; and encoding the plurality of pieces of two-dimensional image information to obtain code stream information.

Abstract: A fly ash-based fire-prevention and extinguishing material with carbon dioxide mineralized and stored, and a preparation method thereof are provided. The preparation method includes: separately weighing 100 parts to 120 parts of water, 1 part to 3 parts of a solid strong alkali, and 20 parts to 40 parts of a fly ash as raw materials, pouring the raw materials into a reactor successively to obtain a resulting mixture, and stirring the resulting mixture at a high rotational speed; adding 10 parts to 20 parts of a solubilizing agent to the reactor, sealing the reactor, introducing carbon dioxide to the reactor at room temperature to maintain a carbon dioxide pressure to obtain a resulting slurry, and stirring the resulting slurry at a high rotational speed; and further introducing carbon dioxide into the reactor to increase the carbon dioxide pressure, and stirring the resulting slurry at a low rotational speed.

Abstract: Provided is a scalable and cost-efficient storage architecture for large-scale datasets, such as Internet-scale datasets that include very large numbers (e.g., billions) of data elements. More particularly, provided is a bifurcated storage architecture that includes a first data index stored by a first set of storage media and a second data index stored by a second set of storage media, where the first set of storage media has a lower latency than the second set of storage media.

Abstract: A method for preparing an antibody, relating to the field of immunology and the field of molecular virology, in particular to the field of diagnosis, prevention and treatment of novel coronavirus. Specifically, provided are a monoclonal antibody against novel coronavirus, and a composition (e.g., a diagnostic agent and a therapeutic agent) containing the antibody. Also provided are the preparation, screening, and use of the antibody.

Abstract: The present invention relates to the fields of immunology and molecular virology, and in particular, to the field of diagnosis, prevention and treatment of a novel coronavirus. Specifically, the present invention relates to an anti-novel coronavirus monoclonal antibody and a composition (for example, a diagnostic agent and a therapeutic agent) containing same. In addition, the present invention also relates to use of the antibody. The antibody of the present invention can be used for diagnosing, preventing and/or treating novel coronavirus infections and/or diseases (for example, novel coronavirus pneumonia) caused by the infections.

Abstract: Provided are a monoclonal antibody against a novel coronavirus and a composition that comprises said antibody. The antibody can be used to diagnose, prevent and/or treat novel coronavirus infections and/or diseases caused by an infection.

Abstract: This application provides an uplink transmit power determining method, a network device, and a storage medium. The method includes: The network device obtains a path loss PL based on a power headroom report reported by a terminal, determines, based on the path loss and an interference margin, a repetition count of UCI of the terminal, and sends the repetition count of the UCI to the terminal. The terminal determines an uplink transmit power based on the repetition count of the UCI. To be specific, the repetition count of the UCI on a user side is adaptively configured based on a PL and an interference, to determine whether the repetition count of the UCI needs to be configured based on a low coverage level for a user currently accessing at a high coverage level, so that a transmit power of the UCI is controlled, and an avalanche effect caused by always selecting full-power uplink transmission is avoided.

Abstract: Disclosed in the present invention are a salt type and crystal type of 4H-pyrazolo[1, 5-alpha]benzimidazole compound and the preparation method and intermediate thereof. The 4H-pyrazolo[1,5-alpha]benzimidazole compound has the structure of Compound 2.

Abstract: This application provides a downlink transmission resource allocation method and apparatus. The method includes determining a first time domain resource length and a second time domain resource length, and adjusting the second time domain resource length if the first time domain resource length is greater than or equal to a preset threshold. The method also includes if a third time domain resource length is greater than or equal to a decreased second time domain resource length, determining the first time domain resource length as a first target time domain resource length, and determining the decreased second time domain resource length as a second target time domain resource length. A first time domain resource is used to switch from a first state to a second state, a second time domain resource is used to receive the downlink data, and a third time domain resource is used to transmit the downlink data.

Abstract: Provided are a series of BTK inhibitors, and specifically disclosed are a compound, pharmaceutically acceptable salt thereof, tautomer thereof or prodrug thereof represented by formula (I), (II), (III) or (IV).

Abstract: Disclosed in the present invention are a salt type and crystal type of 4H-pyrazolo[1, 5-alpha]benzimidazole compound and the preparation method and intermediate thereof.

Abstract: Disclosed in the present invention are a salt type and crystal type of 4H-pyrazolo[1,5-alpha]benzimidazole compound and a preparation method and intermediate thereof.

Abstract: Disclosed in the present invention are a salt type and crystal type of 4H-pyrazolo[1, 5-alpha]benzimidazole compound and the preparation method and intermediate thereof.

Abstract: Disclosed is a series of analogs of 4H-pyrazolo[1,5-?]benzimidazole compound as PARP inhibitors. In particular, disclosed in the invention is a compound as shown by formula (I) or a pharmaceutically acceptable salt thereof as a PARP inhibitor.

Abstract: Provided are a series of BTK inhibitors, and specifically disclosed are a compound, pharmaceutically acceptable salt thereof, tautomer thereof or prodrug thereof represented by formula (I), (II), (III) or (IV).

Abstract: Disclosed is a series of analogues of 4H-pyrazolo[1,5-?]benzimidazole compound as PARP inhibitors. In particular, disclosed in the invention is a compound as shown by formula (I) or a pharmaceutically acceptable salt thereof as a PARP inhibitor.

Abstract: Provided are activated collagen scaffold materials as well as their special fused active restoration factors useful for promoting tissue repair, such as bone damage repair or nerve injury repair. The special fused active restoration factors are fusion proteins comprising a collagen-binding domain (CBD) at N-/C-terminus of cytokines, wherein the collagen-binding domain is a polypeptide consisting of 7-27 amino acid residues with a conservative sequence shown in SEQ ID NO:4 at N-terminus.

Abstract: Provided are activated collagen scaffold materials as well as their special fused active restoration factors useful for promoting tissue repair, such as bone damage repair or nerve injury repair. The special fused active restoration factors are fusion proteins comprising a collagen-binding domain (CBD) at N-/C-terminus of cytokines, wherein the collagen-binding domain is a polypeptide consisting of 7-27 amino acid residues with a conservative sequence shown in SEQ ID NO:12 at N-terminus.